Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for a Phase 1b/2 Clinical Trial of Soquelitinib in China for the Treatment of Atopic Dermatitis
-
Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104
-
Nametag Sets New Paradigm in Enterprise Identity Verification with Bring-Your-Own-Storage for PII
-
Media Advisory - Energy Sector Gains New Edge in Vegetation and Methane Emissions Monitoring with Maxar and Satelytics Partnership
-
Building More Than Homes: Why Keechi Creek Builders Is Houston’s Premier Choice for Custom Living
-
BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System
-
Bryn Pharma Announces First Participant Dosed in PK/PD Trial with Upgraded Nasal Spray Device, Including First-of-Its-Kind, Two-Doses-in-One Nasal Spray Profile
-
DIMERx Awarded Up to $15M by NIDA Under NIH HEAL Initiative® to Advance DMX-101 as a Non-Addictive Oral Therapy for Chronic Pain
-
HealthLynked Partners with Endlink to Accelerate EMR and Hospital System Integration
-
Ovid Therapeutics Enters Agreement with Immedica Pharma AB for Sale of Future Ganaxolone Royalties
-
Webuy Global Ltd. Named One of Asia-Pacific’s Fastest-Growing Companies by Financial Times
-
Fangdd Network Group Ltd. Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
-
Enlightify Inc. Repositions Subsidiary Anteaus to Expand Institutional Crypto Capabilities
-
Report: 1 in 2 Employees Have Excessive Privileged Access—CloudEagle.ai Survey Warns of Escalating Insider Risk due to AI and SaaS Sprawl
-
G2 Recognizes Regula as Identity Verification Leader with 100% Support Satisfaction
-
OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting
-
Basecamp Research Announces Malawi Biodiscovery Partnership in Series of New Collaborations Across Three Continents at UK Government Nature Action Event
-
Horizon Aircraft Partners with Renowned Designer Andrea Mocellin to Shape the Future of Air Mobility
-
Sales Order Management & Collaboration from Elemica® Achieves SAP® Certified Integration with RISE with SAP S/4HANA® Cloud
-
BigCommerce and Feedonomics Team Up with Perplexity to Help Brands Excel at AI Product Search
-
PATTISON Outdoor Introduces ‘Digital Twins’: A Groundbreaking Campaign Creative Planning Tool
-
Getty Realty Corp. to Report Second Quarter 2025 Financial Results
-
CapEx Finance Index (CFI) May 2025: Demand Rose; Financial Conditions Remained Healthy
-
ARKO Corp. Unveils its First Enhanced Food and Beverage Pilot Store in Ashland, VA, Launches New Food Concept fascraves
-
Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025
-
GasBuddy Celebrates 25 Years with Launch of GasBuddy Rewards, Expanded Savings Opportunities
-
Salsify Names Cory McIntyre as Vice President of Global Network, Strengthening Commitment to PXM Innovation
-
Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B
-
Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences
-
Elanders AB: Charles Ickes appointed Group Chief Operating Officer
-
BIO-key Joins ISMS Forum to Advance Cybersecurity and Identity Management Best Practices in Spain
-
ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership with Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol Efflux Mediator™ VAR 200
-
Yellow Network Appoints Alessio Treglia and Hongtao as CTOs to Accelerate Chain-Agnostic Web3 Infrastructure
-
Stabilization Notice - PRE STAB - DOLCETTO HOLDCO S.P.A.
-
Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
-
Change in Hepsor AS articles of association
-
Liberty Defense has Appointed the Honorable Thomas Monheim, Former Inspector General for the US Intelligence Community & Current Executive Director, Global Compliance Investigations and Ombuds, fo
-
Coppernico Metals Announces the Voting Results of its 2025 Annual General Meeting
-
Form 8.5 (EPT/RI) - Anexo Group Plc
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
Form 8.5 (EPT/RI) - Inspired Plc
-
Form 8.5 (EPT/RI) - H & T Group
-
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
-
Cognition Therapeutics Provides Regulatory Update on Zervimesine (CT1812) in Alzheimer’s Disease and Dementia with Lewy Bodies (DLB)
-
ThreeD Capital Inc. Congratulates DeLorean on Token Launch and Web 3 Expansion
-
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer
-
Digital Asset Technologies Portfolio Company, LiquidLink to Host Weekly X Spaces Exploring Real World Assets on the XRP Ledger, Bitcoin Lightning Network and Other Blockchain Networks
-
Volatus Aerospace Secures Strategic National Contract to Power Canada’s Data-Driven Agriculture Movement
-
Q-Gold Resources has commenced the third phase of diamond drilling at the historic Foley Shaft area within its Mine Centre project in Northern Ontario
-
Oncotelic Therapeutics Announces Publication of Landmark Study on TGFB2 Gene Methylation as a Positive Prognostic Marker in Pancreatic Cancer
